Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4854705 | 0.98 | CYP2D6 (0.41) | CYP2D6CYP2C19 | |
| SCHEMBL354239 | 0.78 | CYP2D6 (0.50) | CYP2D6CYP2C19 | |
| SCHEMBL9129579 | 0.76 | CYP2D6 (0.41) | CYP2D6CYP2C19 | |
| SCHEMBL17768026 | 0.70 | CYP2D6 (0.44) | CYP2D6CYP2C19 | |
| Oxalic Acid SCHEMBL14842505 | 0.67 | CYP2D6 (0.41) | CYP2D6CYP2C19 | |
| SCHEMBL203297 | 0.67 | CYP2D6 (0.46) | CYP2D6CYP2C19 | |
| SCHEMBL842714 | 0.66 | — | — | |
| SCHEMBL856065 | 0.66 | — | — | |
| SCHEMBL4528459 | 0.66 | — | — | |
| SCHEMBL3111890 | 0.65 | CYP2D6 (0.55) | CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1697400-B1 | BIPHENYL-SUBSTITUTED ANTIBACTERIAL MACROCYCLES | AICURIS GMBH & CO KG (DE) | 2011-05-25 | — | — | EP | disclosed |
| EP-1797110-B1 | ANTIBACTERIAL AMIDE MACROCYCLES IV | AICURIS GMBH & CO KG (DE) | 2011-01-12 | — | — | EP | disclosed |
| WO-2005118613-A2 | ANTIBACTERIAL AMIDE MACROCYCLES | AICURIS GMBH & CO.KG (DE) | 2005-12-15 | — | — | WO | disclosed |
| US-20050256037-A1 | Antibacterial amide macrocyles | BAYER HEALTHCARE AG (DE) | 2005-11-17 | — | — | US | disclosed |
| WO-2005033129-A1 | ANTIBACTERIAL AMIDE MACROCYCLES | BAYER HEALTHCARE AG (DE) | 2005-04-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256037-A1 | Antibacterial amide macrocyles | AADAC, PAM, NOD2 | CYP2D6 1275/4885CYP2C19 399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.